Muscle Strength and Functional Autonomy of Elderly Women

NCT01553396 — Completed, 35 participants, Euro-American Network of Human Kinetics

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Muscle Strength and Functional Autonomy of Normo-IGF-1 Elderly Women With Skeletal Muscle Dysfunctions

RegistryNCT01553396
StatusCompleted
Study typeObservational
Enrollment35 (Actual)
SponsorEuro-American Network of Human Kinetics (Other)
ConditionsMuscle, Ligament and Fascia Disorders
Datesstart 2009-01-01, primary completion 2009-02-01, completion 2009-04-01, first posted 2012-03-14, last updated 2012-03-14

Related Papers Related Patents Related Grants Related Experts
All trials for Muscle, Ligament and Fascia Disorders

-Summary

This study shows an evaluation of the correlation between the muscle strength levels and functional autonomy of elderly women.

Expand all sections  ·  Collapse all

+Detailed description

The aim of this study was to evaluate the correlation between the muscle strength levels and functional autonomy of elderly women with impaired muscle-skeletal system depending on the normal IGF-1 level. The target-population was composed by elderly women aged between 60 and 75 years (age: 67.79 ± 5.11 years, BMI: 28.01 ± 5.4), residents of an asylum, with IGF-1 levels within the normal values for the age (normo-IGF-1). Evaluations of the muscle strength (1-RM test) and the functional autonomy (GDLAM Protocol) in the performance of activities of daily living (ADL), and a measurement of basal serum levels of IGF-1 (Chemiluminescence method) were performed.

+Eligibility

Sex: Female, ages: 60 Years to 75 Years

Inclusion Criteria:

* present a muscle-skeletal dysfunction, such as osteoporosis, arthritis, tendinitis, but being able to perform their ADL without help from others;
* did not practice physical activity for at least 12 months;
* provide a normal IGF-1 level for their age;

Exclusion Criteria:

* elderly women unfit to perform the strength and functional autonomy tests for the medical assessment;

+Investigators

  • Estélio HM Dantas, DSc, Study chair, University Castelo Branco (Rio de Janeiro, Brazil)